A Unique Roadblock for Pfizer’s Osteoarthritis Drug

We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?

Read more »

FDA, Clinical Trial News: $ABIO, $GENZ, $KV-A, $SLXP

Shares of ARCA Biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing.

Read more »

Protalix Granted Fast-Track Review for Gaucher Drug

The U.S. Food and Drug Administration has granted a fast-track review to Protalix BioTherapeutics’ experimental treatment for Gaucher disease.

Read more »

State of the Art: Anti-Adhesion Barriers

Many patients are concerned about the external scars that form following surgical procedures, but a much greater risk can come from internal scarring. Adhesions are a type of post-surgical scar tissue that forms between two internal organs or surfaces that are normally separated.

Read more »